CEBP Grants Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnette, P.
Right arrow Articles by Keller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnette, P.
Right arrow Articles by Keller, C.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 304-313, February 2004
© 2004 American Association for Cancer Research

High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population

Phillip Barnette1, Rebecca Scholl2, Mary Blandford1, Linda Ballard2, Alexander Tsodikov3, Jalene Magee2, Susana Williams2, Margaret Robertson2, Francis Ali-Osman4, Richard Lemons1 and Charles Keller1

1 Division of Pediatric Hematology-Oncology, Department of Pediatrics, 2 Genomics Core Facility, and 3 Biomedical Statistics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, and 4 Section of Molecular Therapeutics, Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Polymorphisms of glutathione S-transferase (GST) enzymes have been correlated with altered risk of several cancers, as well as altered response and toxicity from cancer chemotherapy. We report a low cost, highly reproducible and specific PCR-based high-throughput assay for genotyping different GSTs designed for use in large clinical trials. In comparison to an alternative genotyping method (single nucleotide extension), the sensitivity and specificity of the high throughput assay was shown to be 92 and 97%, respectively, depending on the source of genomic DNA. Using the high-throughput assay, we demonstrate by multivariate analysis an increased risk of acute lymphoblastic leukemia, glial brain tumors, and osteosarcoma for patients carrying nonnull alleles of GSTM1 and/or GSTT1.




This article has been cited by other articles:


Home page
Radiat Prot DosimetryHome page
A. P. Chokkalingam and P. A. Buffler
Genetic susceptibility to childhood leukaemia
Radiat Prot Dosimetry, December 1, 2008; 132(2): 119 - 129.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.